1-9 of 9
Mary Ann Anderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma

Open Access
Clinical Trials & Observations
Sasanka M. Handunnetti, Amit Khot, Piers Blombery, Kate Burbury, Philip A Thompson, David Ritchie, Rodney John Hicks, Glenda Burke, Rachel M Koldej, Mathias Bressel, Juliana L Di Iulio, David A Westerman, Stephen Lade, Andrew W. Roberts, John F Seymour, Constantine S. Tam, Mary Ann Anderson
Journal: Blood Advances
Blood Adv bloodadvances.2025016646.
https://doi.org/10.1182/bloodadvances.2025016646
Published: 2025
Includes: Supplemental data
Journal Articles

Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL

Open Access
Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, Christina Papangelou, Evangelia Minga, Celso Arrais-Rodrigues, Sotiria Dimou-Besikli, Dr, Amalia Cerutti, Michael Doubek, Lisbeth Enggaard, Blanca Espinet, Blanca Ferrer-Lores, Jose Antonio Garcia Vela, Massimo Gentile, Eva Gimeno Vazquez, Odit Gutwein, Yair Herishanu, Paula Jabłonowska-Babij, Ozren Jaksic, Pär Josefsson, Elżbieta Kalicińska, Maria Kislova, Enrico Lista, Ioannis Kotsianidis, Juan Marquet, Enrica Antonia Antonia Martino, Ciaran P McAuley, Maria J Mela-Osorio, Riccardo Moia, Claudia Mosquera Rubal, Eugene A. Nikitin, Miguel Arturo Pavlovsky, Verena Pfister, Emine Merve Savaş, Lydia Scarfò, Matjaz Sever, Lev Shvidel, Martin Simkovic, Niki Stavroyianni, Persefoni Talimtzi, Antigoni Tranidou, Andrea Visentin, George Vrachiolias, Ewa Wasik-Szczepanek, Tomasz Wróbel, Münci Yağcı, Alessandro Cellini, Anastasia Chatzidimitriou, Gianluca Gaidano, Mary Ann Anderson, Matthew S. Davids, Jennifer R. Brown, Carsten Utoft Niemann, Kostas Stamatopoulos, Paolo Ghia, Inhye E. Ahn, Maya Koren-Michowitz
Journal: Blood Advances
Blood Adv bloodadvances.2025017755.
https://doi.org/10.1182/bloodadvances.2025017755
Published: 2025
Includes: Supplemental data
Journal Articles

Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

Open Access
Clinical Trials & Observations
Constantine S Tam, Mary Ann Anderson, Martin Simkovic, Paolo Ghia, Ian W. Flinn, Kamel Laribi, Stephen S. Opat, Gavin Cull, Talha Munir, Anders Österborg, Alessandra Tedeschi, Megan (Der Yu) Wang, Andy H. Szeto, Heather Allewelt, Tommi Salmi, Jessica Li, Linlin Xu, Kenneth Wu, Remus Vezan, Mazyar Shadman, Jennifer R. Brown
Journal: Blood Advances
Blood Adv bloodadvances.2025015986.
https://doi.org/10.1182/bloodadvances.2025015986
Published: 2025
Includes: Supplemental data
Journal Articles

Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis

Free
Clinical Trials & Observations
Gemma K. Reynolds, Marsali Maclean, Edward R. Scheffer Cliff, Benjamin W. Teh, Karin A. Thursky, Monica A. Slavin, Mary Ann Anderson, Eliza A. Hawkes
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3555–3559.
https://doi.org/10.1182/bloodadvances.2024012916
Published: 2024
Includes: Supplemental data
Journal Articles

Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells

Free
Clinical Trials & Observations
Charis E. Teh, Hongke Peng, Meng-Xiao Luo, Tania Tan, Marie Trussart, Lauren J. Howson, Chong Chyn Chua, Christine Muttiah, Fiona Brown, Matthew E. Ritchie, Andrew H. Wei, Andrew W. Roberts, Vanessa L. Bryant, Mary Ann Anderson, Geoffrey J. Lindeman, David C. S. Huang, Rachel Thijssen, Daniel H. D. Gray
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2733–2745.
https://doi.org/10.1182/bloodadvances.2022008221
Published: 2023
Includes: Supplemental data
Journal Articles

Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors

Free
Ella R. Thompson, Tamia Nguyen, Yamuna Kankanige, John F. Markham, Mary Ann Anderson, Sasanka M. Handunnetti, Rachel Thijssen, Paul Sung-Hao Yeh, Constantine S. Tam, John F. Seymour, Andrew W. Roberts, David A. Westerman, Piers Blombery
Journal: Blood Advances
Blood Adv (2022) 6 (2): 503–508.
https://doi.org/10.1182/bloodadvances.2021006211
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition

Free
Clinical Trials & Observations
Thomas E. Lew, Victor S. Lin, Edward R. Cliff, Piers Blombery, Ella R. Thompson, Sasanka M. Handunnetti, David A. Westerman, Bryone J. Kuss, Constantine S. Tam, David C. S. Huang, John F. Seymour, Andrew W. Roberts, Mary Ann Anderson
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4054–4058.
https://doi.org/10.1182/bloodadvances.2021005083
Published: 2021
Includes: Supplemental data
Journal Articles

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy

Free
Clinical Trials & Observations
Joanne E. Davis, Sasanka M. Handunnetti, Mandy Ludford-Menting, Chia Sharpe, Piers Blombery, Mary Ann Anderson, Andrew W. Roberts, John F. Seymour, Constantine S. Tam, David S. Ritchie, Rachel M. Koldej
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4849–4859.
https://doi.org/10.1182/bloodadvances.2020002810
Published: 2020
Includes: Supplemental data
Journal Articles

Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months

Free
Clinical Trials & Observations
Thomas E. Lew, Mary Ann Anderson, Victor S. Lin, Sasanka M. Handunnetti, Neil A. Came, Piers Blombery, David A. Westerman, Meaghan Wall, Constantine S. Tam, Andrew W. Roberts, John F. Seymour
Journal: Blood Advances
Blood Adv (2020) 4 (1): 165–173.
https://doi.org/10.1182/bloodadvances.2019000864
Published: 2020
Includes: Supplemental data